CIK: 0001577524 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value ($000): $1,043,262 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 16,390,000 | $183,240 | 17.6% | $11.52 | -8.3% | COM CL A | 46333X108 |
| BIIB | BIOGEN INC | 643,000 | $179,879 | 17.2% | $278.12 | -3.0% | COM | 09062X103 |
| GILD | Gilead Sciences Inc | 2,697,400 | $174,332 | 16.7% | $53.36 | 0.0% | COM | 375558103 |
| ALKS | Alkermes PLC | 7,950,000 | $148,506 | 14.2% | $18.70 | +9.5% | SHS | G01767105 |
| — | Alexion Pharmaceuticals Inc | 650,440 | $99,458 | 9.5% | $108.59 | — | COM | 015351109 |
| BCRX | BioCryst Pharmaceuticals Inc | 7,637,700 | $77,675 | 7.4% | $4.60 | +124.2% | COM | 09058V103 |
| INVA | INNOVIVA INC | 6,414,000 | $76,647 | 7.3% | $13.01 | -7.1% | COM | 45781M101 |
| — | MERSANA THERAPEUTICS INC | 4,005,600 | $64,810 | 6.2% | $9.57 | — | COM | 59045L106 |
| — | VOR BIOPHARMA INC | 707,010 | $30,472 | 2.9% | $43.10 | — | COM | 929033108 |
| — | SARISSA CAPITAL ACQUISITN CO | 3,333,333 | $4,999 | 0.5% | $1.50 | — | W EXP 10/23/202 | G7823W110 |
| — | REGULUS THERAPEUTICS INC | 1,851,851 | $2,888 | 0.3% | $1.25 | — | COM NEW | 75915K200 |
| — | MIRATI THERAPEUTICS INC | 1,000 | $171 | 0.0% | $42.00 | — | COM | 60468T105 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,000 | $164 | 0.0% | $128.37 | +28.2% | SHS USD | G50871105 |
| — | INTERCEPT PHARMACEUTICALS INC | 950 | $21 | 0.0% | $79.88 | — | COM | 45845P108 |